YouTube2Text

Systemic Lupus Erythematosus Explained Clearly (SLE Explained) — Transcript

by Rhesus Medicine · 1,369 words · 283 segments · language en · Watch on YouTube

Full transcript

  1. 0:04Systemic lupus erythematosus,
  2. 0:07often called SLE or just lupus, is a
  3. 0:11chronic systemic autoimmune disorder
  4. 0:14featuring multi-organ involvement and a
  5. 0:16wide range of potential clinical
  6. 0:18features.
  7. 0:20The name itself reflects the widespread
  8. 0:23effect in the body with systemic
  9. 0:25and lupus is Latin for wolf and was
  10. 0:28coined to describe erosive facial
  11. 0:31lesions that historically were thought
  12. 0:33to resemble a wolf's bite.
  13. 0:35Erythematosus is derived from Greek,
  14. 0:38meaning red, reflecting the redness and
  15. 0:40inflammation of the skin.
  16. 0:43It most commonly affects females between
  17. 0:45puberty and menopause with a female to
  18. 0:48male ratio moving from approximately 3:1
  19. 0:51in children up to 15:1 in adults with
  20. 0:55most people being diagnosed before the
  21. 0:58age of 50.
  22. 1:00The pathophysiology is linked to the
  23. 1:03autoimmune nature
  24. 1:04where IgG antibodies form mostly against
  25. 1:08nuclear proteins and double-stranded
  26. 1:10DNA.
  27. 1:12Usually, cells going through apoptosis,
  28. 1:15that is programmed cell death, and
  29. 1:17cellular debris are cleared quickly by
  30. 1:20phagocytes, which minimizes the exposure
  31. 1:23of nuclear proteins to the immune
  32. 1:25system.
  33. 1:27In SLE, however, this may be impaired
  34. 1:30and antibodies termed antinuclear
  35. 1:32antibodies
  36. 1:34are formed against various nuclear
  37. 1:36components,
  38. 1:37including nucleic acids.
  39. 1:40More specific examples of antinuclear
  40. 1:42antibodies are those against spliceosome
  41. 1:45components, called anti-Smith
  42. 1:47antibodies, as well as formation of
  43. 1:50anti-double-stranded DNA antibodies.
  44. 1:53Antinuclear antibodies, generally, are
  45. 1:56positive in 97% of SLE patients, but
  46. 2:00they are not specific as other
  47. 2:02conditions like rheumatoid arthritis can
  48. 2:04have positivity.
  49. 2:06But these examples of anti-Smith and
  50. 2:09anti-double-stranded DNA antibodies are
  51. 2:12highly specific.
  52. 2:14Other antibodies can also form such as
  53. 2:16antiphospholipid antibodies, for
  54. 2:18example, lupus anticoagulant and beta-2
  55. 2:22glycoprotein 1 antibodies,
  56. 2:25which are found in 30 to 40% of SLE
  57. 2:28patients, but are not specific despite
  58. 2:31the name. Also note that antibodies can
  59. 2:33be present before the onset of clinical
  60. 2:36manifestations.
  61. 2:37Overall, these autoantibodies lead to
  62. 2:40immune complexes being formed with the
  63. 2:42self antigens that can be deposited into
  64. 2:45organs throughout the body
  65. 2:47leading to inflammation and complement
  66. 2:50activation, and as such leading to
  67. 2:53tissue injury.
  68. 2:54This gives the systemic involvement and
  69. 2:57wide range [clears throat] of clinical
  70. 2:58findings.
  71. 2:59SLE is primarily mediated by immune
  72. 3:02complex deposition and is an example of
  73. 3:05a type 3 hypersensitivity reaction.
  74. 3:08The exact reason why this happens is not
  75. 3:10clear, but is thought to be the result
  76. 3:13of an interaction between an
  77. 3:15environmental trigger in a genetically
  78. 3:17susceptible host. And given the high
  79. 3:20female to male ratio, it is thought that
  80. 3:23hormonal factors may also contribute.
  81. 3:26It has around 46% heritability, meaning
  82. 3:29the degree to which the variation in
  83. 3:31disease risk is caused by genetic
  84. 3:34differences,
  85. 3:35and many predisposing genes have been
  86. 3:37identified. These can have roles in the
  87. 3:40innate or adaptive immune response,
  88. 3:42potentially promoting loss of
  89. 3:44self-tolerance and survival of
  90. 3:46autoreactive B cells or self-reactive
  91. 3:49clones, as well as genes affecting cell
  92. 3:52debris clearance.
  93. 3:54Non-infectious environmental factors
  94. 3:56include smoking, certain medications
  95. 3:59such as procainamide, sulfasalazine,
  96. 4:02phenytoin, and carbamazepine as
  97. 4:04examples.
  98. 4:06Air pollution and occupational exposure
  99. 4:09such as free crystalline silica.
  100. 4:12Infectious triggers can include
  101. 4:14parvovirus B19, Epstein-Barr virus,
  102. 4:17cytomegalovirus,
  103. 4:19and HIV.
  104. 4:21As mentioned, the clinical features in
  105. 4:23SLE can be widespread and varied between
  106. 4:26individuals, often making diagnosis
  107. 4:28challenging.
  108. 4:30To make them easier to remember, we'll
  109. 4:32use the mnemonic SOAP BRAIN MD.
  110. 4:36S is for serositis, which can include
  111. 4:38pericarditis or pleuritis, as well as
  112. 4:41pleural or pericardial effusions, and O
  113. 4:44is for oral ulcers.
  114. 4:46A is for arthritis, which is typically
  115. 4:48symmetrical, deforming, and non-erosive,
  116. 4:52affecting multiple joints, and an
  117. 4:54example of this is Jaccoud's
  118. 4:55arthropathy, which is the result of
  119. 4:57inflammation of the joint capsule and
  120. 4:59ligaments leading to laxity rather than
  121. 5:02bony damage itself.
  122. 5:05Musculoskeletal involvement is seen in
  123. 5:07around 90% of cases.
  124. 5:10P is for photosensitivity,
  125. 5:12with the cutaneous manifestations being
  126. 5:14exacerbated by UV light exposure.
  127. 5:17The B in SOAP BRAIN is for blood,
  128. 5:20which can feature anemia,
  129. 5:22thrombocytopenia, or leukopenia, and if
  130. 5:25all together are termed pancytopenia,
  131. 5:28and autoimmune hemolysis can also be
  132. 5:30present.
  133. 5:31R is for renal involvement seen in
  134. 5:34around 1/3 of cases, as lupus nephritis
  135. 5:37can result from immune complex
  136. 5:38deposition within the kidney leading to
  137. 5:41glomerulonephritis,
  138. 5:43and is associated with increased
  139. 5:44mortality.
  140. 5:46Manifestations can include proteinuria,
  141. 5:49hematuria, unexplained hypertension, and
  142. 5:52elevated creatinine levels.
  143. 5:55I also include Raynaud's phenomenon here
  144. 5:57under R, where there can be changes in
  145. 5:59color of the extremities, for example,
  146. 6:01in cold or stress.
  147. 6:04A is for the presence of autoantibodies,
  148. 6:06particularly antinuclear antibodies, and
  149. 6:09also includes non-scarring alopecia. The
  150. 6:13I is for immunological criteria, such as
  151. 6:15the more specific anti-double-stranded
  152. 6:17DNA or anti-Smith antibodies,
  153. 6:20but also antiphospholipid antibodies and
  154. 6:23complement proteins.
  155. 6:25N is for neuropsychiatric
  156. 6:26manifestations, including seizures,
  157. 6:29peripheral neuropathy, as well as
  158. 6:31features such as delirium or psychosis.
  159. 6:35The MD portion, M stands for malar rash,
  160. 6:38also known as a butterfly rash affecting
  161. 6:41the cheeks and nose, and typically
  162. 6:43sparing the nasolabial folds, seen in
  163. 6:46around 30 to 40% of cases.
  164. 6:50D is for discoid lupus, mostly featuring
  165. 6:53red coin-shaped scaly lesions on the
  166. 6:55face and scalp that can cause scarring.
  167. 6:59The MD portion features examples of
  168. 7:01cutaneous lupus,
  169. 7:03which itself has multiple subtypes,
  170. 7:05including acute, subacute, and chronic,
  171. 7:08of which discoid lupus is an example.
  172. 7:12Currently, the diagnostic criteria most
  173. 7:14commonly used are the EULAR and American
  174. 7:17College of Rheumatology, which largely
  175. 7:20include the clinical manifestations
  176. 7:22we've covered above on a points-based
  177. 7:24system, but before looking at that,
  178. 7:26there is an entry criterion that needs
  179. 7:28to be met,
  180. 7:29which is the presence of antinuclear
  181. 7:31antibodies at a titer of 1 to 80 on
  182. 7:34HEp-2 cells, a cell type used as a gold
  183. 7:38standard for detecting antinuclear
  184. 7:40antibodies.
  185. 7:41Then, the additive criteria are
  186. 7:43included, which feature clinical and
  187. 7:45immunological domains.
  188. 7:47Occurrence of one criterion on one
  189. 7:49occasion is enough to count, but should
  190. 7:52not be counted if there is an
  191. 7:53explanation more likely than SLE. There
  192. 7:57must be at least one clinical criterion
  193. 7:59met, as well as 10 points or more
  194. 8:01scored.
  195. 8:02And within each domain, only the highest
  196. 8:04criterion is counted.
  197. 8:06The clinical domains include
  198. 8:08constitutional, such as fever,
  199. 8:10hematological, including the leukopenia,
  200. 8:12thrombocytopenia,
  201. 8:14and autoimmune hemolysis,
  202. 8:16neuropsychiatric, including the
  203. 8:18delirium, psychosis, and seizures,
  204. 8:21mucocutaneous, including the
  205. 8:23non-scarring alopecia,
  206. 8:25oral ulcers, subacute cutaneous or
  207. 8:28discoid lupus, or acute cutaneous lupus,
  208. 8:32serosal,
  209. 8:33featuring the pleural or pericardial
  210. 8:35effusion or pericarditis,
  211. 8:38musculoskeletal, meaning joint
  212. 8:40involvement, and renal, featuring
  213. 8:42proteinuria or any of the lupus
  214. 8:45nephritis classes, with each offering
  215. 8:47different numbers of points.
  216. 8:51The immunological domains include
  217. 8:52antiphospholipid antibodies, like
  218. 8:55anticardiolipin,
  219. 8:56anti-beta-2-glycoprotein-1,
  220. 8:58and lupus anticoagulant,
  221. 9:01complement proteins, meaning low C3 or
  222. 9:03low C4 or both,
  223. 9:06and SLE-specific antibodies,
  224. 9:09in particular, anti-double-stranded DNA
  225. 9:12or anti-Smith antibodies.
  226. 9:15As mentioned, a positive entry criterion
  227. 9:17and 10 points or more would meet the
  228. 9:19criteria for a diagnosis.
  229. 9:23Management often requires
  230. 9:24multidisciplinary involvement, given the
  231. 9:27widespread potential clinical effects,
  232. 9:29with an individualized approach.
  233. 9:31Treatment aims to induce remission or
  234. 9:34the lowest disease activity if remission
  235. 9:36is not possible measured by the SLE
  236. 9:39disease activity index
  237. 9:41as well as regular screening for organ
  238. 9:43damage.
  239. 9:44Non-pharmacological measures can include
  240. 9:47sun protection and avoidance of
  241. 9:49ultraviolet exposure,
  242. 9:51smoking cessation, and the Mediterranean
  243. 9:53diet has been associated with lower
  244. 9:56cardiovascular risk, disease activity,
  245. 9:59and protection against organ damage.
  246. 10:02Exercise, typically aiming for 30
  247. 10:04minutes or more at least five times a
  248. 10:06week, is also recommended. And there is
  249. 10:08also some evidence to suggest CBT and
  250. 10:11psychoeducation may be adjuncts to
  251. 10:14medical therapy to improve fatigue,
  252. 10:17depression, and improve quality of life.
  253. 10:21Pharmacological management commonly
  254. 10:23includes hydroxychloroquine as a
  255. 10:25first-line agent, which is shown to
  256. 10:27reduce disease flares and mortality.
  257. 10:30Corticosteroids may also be added as
  258. 10:33part of this first-line treatment.
  259. 10:35And in renal cases, most patients do
  260. 10:37receive both.
  261. 10:39Retinal screening is recommended due to
  262. 10:42the potential risk of toxic retinopathy
  263. 10:45with hydroxychloroquine.
  264. 10:47If not responding to first-line, an
  265. 10:49immunosuppressant such as methotrexate
  266. 10:52or mycophenolate can be added, or a
  267. 10:54biological agent such as belimumab,
  268. 10:57which is a monoclonal antibody targeting
  269. 11:00B lymphocyte stimulator,
  270. 11:02or anifrolumab, a monoclonal antibody
  271. 11:05targeting type 1 interferon receptors.
  272. 11:09These can be added if not responding to
  273. 11:11first-line.
  274. 11:12Depending on the clinical system
  275. 11:14involvement, further [snorts] medication
  276. 11:16may be useful. For example, nonsteroidal
  277. 11:18anti-inflammatories like ibuprofen or
  278. 11:21naproxen can help with joint
  279. 11:23involvement, though caution needs to be
  280. 11:25taken due to the risk of nephrotoxicity.
  281. 11:28And others could include antidepressants
  282. 11:30or antipsychotics in some
  283. 11:32neuropsychiatric cases.

About this transcript

This page contains the full transcript of Systemic Lupus Erythematosus Explained Clearly (SLE Explained) by Rhesus Medicine, generated from the public captions YouTube serves with the video. The transcript has 1,369 words across 283 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.